Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.

Published in:

Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac325

By:

• Gupta, Amita;
• Sun, Xin;
• Krishnan, Sonya;
• Matoga, Mitch;
• Pierre, Samuel;
• McIntire, Katherine;
• Koech, Lucy;
• Faesen, Sharlaa;
• Kityo, Cissy;
• Dadabhai, Sufia S;
• Naidoo, Kogieleum;
• Samaneka, Wadzanai P;
• Lama, Javier R;
• Veloso, Valdilea G;
• Mave, Vidya;
• Lalloo, Umesh;
• Langat, Deborah;
• Hogg, Evelyn;
• Bisson, Gregory P;
• Kumwenda, Johnstone

Publication type:

Article